Contact this trialFirst, we need to learn more about you.
Lenalidomide + Ipilimumab for Blood Cancers
Recruiting3 awardsPhase 2
Houston, Texas
This trial looks at the side effects of two cancer treatments: lenalidomide and ipilimumab. Lenalidomide stimulates or suppresses the immune system, and ipilimumab helps the body's immune system attack the cancer.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.